Heme‐induced corpus cavernosum relaxation and its implications for priapism in sickle cell disease: a mechanistic insight
Andrology · 2024
DOI: 10.1111/andr.13599 ↗Kurz gefasst
Fachartikel in der Zeitschrift Andrology, 2024. Verfasst von Dalila Andrade Pereira und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmacology, São Francisco University Medical School, Bragança Paulista, São Paulo, SP, Brazil. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Priapism, Muscle Relaxation, Penis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: São Paulo Research Foundation, Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Background
Patients with sickle cell disease (SCD) experience intravascular hemolysis, leading to elevated plasma heme levels. This phenomenon has been associated with increased priapism in men with SCD. The heme group can be metabolized by heme oxygenase (HO), generating carbon monoxide (CO), which is known to promote smooth muscle relaxation via soluble guanylyl cyclase (sGC)–cyclic guanosine monophosphate (cGMP). However, the effects of heme on the relaxation responses of corpus cavernosum (CC) have not been investigated.
Objectives
To evaluate the functional and biochemical effects of the heme group on mouse CC smooth muscle in vitro. Materials and methods Male C57BL/6 mice were used. CC tissues were mounted in organ baths. Measurement of cGMP in mice CC was evaluated.
Results
The cumulative addition of heme concentrations promoted the relaxation of CC. HO inhibitor (1J, 100 μM) or sGC inhibitor (ODQ, 10 μM) blocked the relaxing effect of the heme group. Pre‐incubation of CC with heme (100 μM) enhanced relaxation induced by acetylcholine, sodium nitroprusside, and nitrergic relaxation (electrical field stimulation), which was abolished by 1J or ODQ. The heme group increased the cGMP production in CC, which was abolished by 1J or ODQ. cGMP levels were significantly higher in CC treated with heme, and pre‐incubation with compound 1J or ODQ abolished the effect of heme in raising cGMP levels. Discussion and conclusion The HO–CO–sGC–cGMP pathway appears to play a crucial role in promoting CC relaxation. Our study provides novel insight into the role of group heme in CC relaxation and its potential contribution to priapism in SCD. Heme may serve as a pharmacological target for new therapies to prevent priapism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Pharmacology, São Francisco University Medical School, Bragança Paulista, São Paulo, SP, Brazil.
- Department of Pharmacology, Universidade Federal de São Paulo, Escola Paulista de Medicina, São Paulo, SP, Brazil.
- The James Buchanan Brady Urological Institute and Department of Urology, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
- Hematology and Hemotherapy Center, University of Campinas, Campinas, São Paulo, SP, Brazil.
ORCID-Profile: Fábio Henrique Silva
Förderung
- São Paulo Research Foundation
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
Pereira, D. A., Pereira, D. A., Silveira, T. H. R., Calmasini, F. B., Burnett, A. L., Costa, F. F., & Silva, F. H. (2024). Heme‐induced corpus cavernosum relaxation and its implications for priapism in sickle cell disease: a mechanistic insight. Andrology. https://doi.org/10.1111/andr.13599
Vancouver
Pereira DA, Pereira DA, Silveira THR, Calmasini FB, Burnett AL, Costa FF, et al. Heme‐induced corpus cavernosum relaxation and its implications for priapism in sickle cell disease: a mechanistic insight. Andrology. 2024. doi:10.1111/andr.13599
BibTeX
@article{Pereira2024,
author = {Pereira, Dalila Andrade and Pereira, Danillo Andrade and Silveira, Tammyris Helena Rebecchi and Calmasini, Fabiano Beraldi and Burnett, Arthur L and Costa, Fernando Ferreira and Silva, Fábio Henrique},
title = {Heme‐induced corpus cavernosum relaxation and its implications for priapism in sickle cell disease: a mechanistic insight},
journal = {Andrology},
year = {2024},
doi = {10.1111/andr.13599}
}
EUVIMED